The relationship between study characteristics and the prevalence of medication-related hospitalizations: A literature review and novel analysis

Drug Safety

Volumn 33, Issue 3, 2010, Pages 233-244

  Leendertse, Anne J ^a,b   Visser, Djurre ^c   Egberts, Antoine C G ^a,b   Van Den Bemt, Patricia M L A ^a,d  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

AGE DISTRIBUTION; ARTICLE; DATA ANALYSIS; DATA BASE; DRUG INDUCED DISEASE; DRUG SAFETY; HOSPITALIZATION; HUMAN; MEDICAL DOCUMENTATION; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGE DISTRIBUTION; AGED; CHILD; DATABASES, FACTUAL; EUROPE; HOSPITAL INFORMATION SYSTEMS; HOSPITALIZATION; HUMANS; PATIENT ADMISSION; POPULATION GROUPS; POPULATION SURVEILLANCE; PREVALENCE; PRODUCT SURVEILLANCE, POSTMARKETING; RISK FACTORS; SAFETY MANAGEMENT; SELF MEDICATION;

EID: 76949087618     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11319030-000000000-00000     Document Type: Article

References (103)

1. Kohn L, Corrigan J, Donaldson M. To err is human: building a safer health system. Committee on Quality of Health Care in America, Institute of Medicine. Washington, DC: National Academy Press, 1999
2. Beijer JHM, de Blaey CJ. Hospitalisations caused by ad-verse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002; 24: 46-54
3. Van der Hooft CS, Sturkenboom MCJM, Van Grootheest K, et al. Adverse drug reaction-related hospitalisations: a nationwide study in the Netherlands. Drug Saf 2006; 29: 161-168
4. Van der Hooft CS, Dieleman JP, Siemes C, et al. Adverse drug reaction-related hospitalisations: a population-based cohort study. Pharmacoepidemiol Drug Saf 2008 Apr; 17: 365-371
5. Leendertse AJ, Egberts AC, Stoker LJ, et al. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008 Sep 22; 168: 1890-1896
6. Ferner RE, Aronson JK. Clarification of terminology in medication errors: definitions and classification. Drug Saf 2006; 29: 1011-1022
7. Edwards IR, Aronson JK. Adverse drug reactions: defini-tions, diagnosis, and management. Lancet 2000; 356: 1255-1259
8. Deeks JJ, Higgins JPT, Altman DG, editors. Analysing and presenting results. In: Higgins JPT, Green S, editors. Co-chrane handbook for systematic reviews of interventions 4.2.5 [updated May 2005]. Chichester: John Wiley & Sons Ltd, 2005
9. Miller RR. Hospital admissions due to adverse drug reactions: a report from the Boston Collaborative Drug Surveillance Program. Arch Intern Med 1974; 134: 219-223
10. Levy M, Kewitz H, Altwein W, et al. Hospital admissions due to adverse drug reactions: a comparative study from Jerusalem and Berlin. Eur J Clin Pharmacol 1980; 17: 25-31
11. Larmour I, Dolphin RG, Baxter H, et al. A prospective study of hospital admissions due to drug reactions. Aust J Hosp Pharm 1991; 2: 90-95
12. Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002; 50: 1962-1968
13. Classen DC, Pestotnik SL, Scott Evans R, et al. Compu-terized surveillance of adverse drug events in hospital patients. JAMA 1991; 266: 2847-2851
14. Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a south Indian hospital: their severity and cost involved. Pharmacoepidemiol Drug Saf 2003; 12: 687-692
15. Ibanez L, Laporte JR, Carne X. Adverse drug reactions leading to hospital admission. Drug Saf 1991; 6: 450-459
16. Smith JW, Seidl LG, Cluff LE. Studies on the epidemiology of adverse drug reactions: V. Clinical factors influencing susceptibility. Ann Intern Med 1966; 65: 629-640
17. Sidel VW, Koch-Weser J, Barnett GO, et al. Drug utiliza-tion and adverse reactions in a general hospital. Hospitals 1967; 41: 80-88
18. Caranasos GJ, Steart RB, Cluff LE. Drug-induced illness leading to hospitalisation. JAMA 1974; 228: 713-717
19. Cooke DI, van der Merwe W, Pudifin DJ. Hospital ad-missions for adverse reactions to drugs and deliberate self-poisoning. S Afr Med J 1985; 67: 770-772
20. Lin SH, Lin MS. A survey on drug-related hospitalisation in a community teaching hospital. Int J Clin Pharmacol Ther Toxicol 1993; 31: 66-69
21. Huic M, Mucolic V, Vrhovac B, et al. Adverse drug reac-tions resulting in hospital admission. Int J Clin Pharmacol Ther 1994; 32: 675-682
22. Moore N, Lecointre D, Noblet C, et al. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 1998; 45: 301-308
23. Pouyanne P, Haramburu F, Imbs JL, et al. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. BMJ 2000; 320: 1036
24. Mannesse CK, Derkx FH, de Ridder MA, et al. Con-tribution of adverse drug reactions to hospital admission of older patients. Age Ageing 2000; 29: 35-39
25. Fattinger K, Roos M, Vergeres P, et al. Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine. Br J Clin Pharmacol 2000; 49: 158-167
26. Mjorndal T, Boman MD, Hagg S, et al. Adverse drug re-actions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf 2002; 11: 65-72
27. Schneeweiss S, Hasford J, Gottler M, et al. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 2002; 58: 285-291
28. Von Euler M, Eliasson E, Ohlen G, et al. Adverse drug reactions causing hospitalisation can be monitored from computerized medical records and thereby indicate the quality of drug utilization. Pharmacoepidemiol Drug Saf 2006; 15: 179-184
29. Davidsen F, Haghfelt T, Gram LF, et al. Adverse drug reactions and drug non-compliance as primary causes of admission to a cardiology department. Eur J Clin Pharmacol 1988; 34: 83-86
30. McKenzie MW, Stewart RB, Weiss CF, et al. A pharmacist based study of the epidemiology of adverse drug reactions in pediatric medicine patients. Am J Hosp Pharm 1973; 30: 898-903
31. Mitchel AA, Lacouture PG, Sheehan JE, et al. Adverse drug reactions in children leading to hospital admission. Pediatrics 1988; 82: 24-29
32. Martinez-Mir I, Garcia-Lopez M, Palop V, et al. A pro-spective study of adverse drug reactions as a cause of admission to a paediatric hospital. Br J Clin Pharmacol 1996; 42: 319-324
33. Jonville-Bera AP, Giradeau B, Blanc P, et al. Frequency of adverse drug reactions in children: a prospective study. Br J Clin Pharmacol 2002; 53: 207-210
34. Lamabadusuriya SP, Athiada G. Adverse drug reactions in children requiring hospital admission. Ceylon Med J 2003; 48: 86-87
35. Hermesh H, Shalev A, Munitz H. Contribution of adverse drug reaction to admission rates in an acute psychiatric ward. Acta Psychiatr Scand 1985; 72: 104-110
36. Williamson J, Chopin JM. Adverse reactions to prescribed drugs in the elderly: a multicentre investigation. Age Aging 1980; 9: 73-80
37. Popplewell PY, Henschke PJ. Acute admissions to a ger-iatric assessment unit. Med J Aust 1982; 1: 343-344
38. Smucker WD, Kontak JR. Adverse drug reactions causing hospital admission in anelderly population: experience with a decision algorithm. J Am Board Fam Pract 1990; 3: 105-109
39. Zhang M, Holman CD, Price SD, et al. Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study. BMJ 2009; 338: 145-158
40. Senst BL, Achusim LE, Genest RP, et al. Practical ap-proach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm 2001; 58: 1126-1132
41. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329: 15-19 (Pubitemid 38869995)
42. Zargarzadeh AH, Emami MH, Hosseini F. Drug-related hospital admissions in a generic pharmaceutical system. Clin Exp Pharmacol Physiol 2007; 34: 494-498
43. Waller P, Shaw M, Ho D, et al. Hospital admissions for 'drug-induced' disorders in England: a study using the Hospital Episodes Statistics (HES) database. Br J Clin Pharmacol 2005; 59: 213-219
44. Patel H, Bell D, Molokhia M, et al. Trends in hospital ad-missions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005. BMC Clin Pharmacol 2007; 7: 9
45. Pearson TF, Pittman DG, Longley JM, et al. Factors as-sociated with preventable adverse drug reactions. Am J Hosp Pharm 1994 15; 51: 2268-2272
46. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmac-other 2002; 36: 1331-1336
47. Bigby J, Dunn J, Goldman L, et al. Assessing the prevent-ability of emergency hospital admissions: a method for evaluating the quality of medical care in a primary care faculty. Am J Med 1987; 83: 1031-1036
48. Grymonpre RE, Mitenko PA, Sitar DS, et al. Drug-asso-ciated hospital admissions in older medical patients. J Am Geriatr Soc 1988; 36: 1092-1098
49. Atkin PA, Finnegan TP, Ogle SJ, et al. Functional ability of patients to manage medication packaging: a survey of geriatric inpatients. Age Ageing 1994; 23: 113-116
50. Dartnell JGA, Anderson RP, Chohan V, et al. Hospitali-sation for adverse events related to drug therapy: incidence, avoidability and costs. Med J Aust 1996; 1634: 659-662
51. Raschetti R, Morgutti M, Menniti-Ippolito F, et al. Sus-pected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol 1999; 54: 959-963
52. Green CF, Mottram DR, Rowe PH, et al. Adverse drug reactions as a cause of admission to an acute medical assessment unit: a pilot study. J Clin Pharm Ther 2000; 25: 355-361
53. Wasserfallen J, Livio F, Buclin T, et al. Rate, type and cost of adverse drug reactions in emergency department admissions. Eur J Intern Med 2001; 12: 442-447
54. Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 2001; 31: 199-205
55. Olivier P, Boubles O, Tubery M, et al. Assessing the feasi-bility of using an adverse drug reaction preventability scale in clinical practice: a study in a French emergency department. Drug Saf 2002; 25: 1035-1044
56. Howard RL, Avery AJ, Howard PD, et al. Investigation into the reasons for preventable drug-related admissions to a medical admissions unit: observational study. Qual Saf Health Care 2003; 12: 280-285
57. Capuano A, Motola G, Russo F, et al. Adverse drug events in two emergency departments in Naples, Italy: an observational study. Pharmacol Res 2004; 50: 631-636
58. Juntti-Patinen L, Kuitunen T, Pere P, et al. Drug-related visits to a district hospital emergency room. Basic Clin Pharmacol Toxicol 2006; 98: 212-217
59. Patel KJ, Kedia MS, Bajpai D, et al. Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study. BMC Clin Pharmacol 2007; 7: 8
60. Queneau P, Bannwarth B, Carpentier F, et al. Emergency department visits caused by adverse drug events. Drug Saf 2007; 30: 81-88
61. Alexopoulou A, Dourakis SP, Mantzoukis D, et al. Adverse drug reactions as a cause ofhospital admissions: a 6-month experienceinasingle center inGreece. Eur J Intern Med 2008; 19: 505-510
62. Hopf Y, Watson M, Williams D. Adverse-drug-reaction related admissions to a hospital in Scotland. Pharm World Sci 2008; 30: 854-862
63. Zed PJ, Abu-Laban RB, Balen RM, et al. Incidence, se-verity and preventability of medication-related visits to the emergency department: a prospective study. CMAJ 2008 Jun; 178: 1563-1569
64. McKenney JM, Harrison WI. Drug-related hospital ad-missions. Am J Hosp Pharm 1976; 33: 792-795
65. Ghose K. Hospital bed occupancy due to drug-related problems. J Royal Soc Med 1980; 73: 853-856
66. Bergman U, Wiholm BE. Drug-related problems causing admission to a medical clinic. Eur J Clin Pharmacol 1981; 20: 193-200 (Pubitemid 11087485)
67. Ramsay LE, Freestone S, Silas JH. Drug-related acute medical admissions. Human Toxicol 1982; 1: 379-386
68. Lakshmanan MC, Hershey CO, Breslau D. Hospital ad-missions caused by iatrogenic disease. Arch Intern Med 1986; 146: 1931-1934
69. Ives TJ, Bentz EJ, Gwyther RE. Drug-related admissions to a family medicine inpatient service. Arch Intern Med 1987; 147: 1117-1120
70. Hallas J, Harvald B, Gram LF, et al. Drug-related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 1990; 228: 83-90
71. Stanton LA, Peterson GM, Rumble RH, et al. Drug-related admissions to an Australian hospital. J Clin Pharm Ther 1994; 19: 341-347
72. Lin Wu FL, Yang CC, Shen LJ, et al. Adverse drug reac-tions in a medical ward. J Formos Med Assoc 1996; 95: 241-246
73. Nelson KM, Talbert RL. Drug-related hospital admis-sions. Pharmacotherapy 1996; 16: 701-707
74. Major S, Badr S, Bahlawan L, et al. Drug-related hospita-lisation at a tertiary teaching centre in Lebanon: incidence, associations, and relation to self-medicating behavior. Clin Pharmacol Ther 1998; 64: 450-461
75. Gholami K, Shalviri G. Factors associated with prevent-ability, predictability, and severity of adverse drug reactions. Ann Pharmacother 1999; 33: 236-240
76. Jha AK, Kuperman GJ, Rittenberg E, et al. Identifying hospital admissions due to adverse drug events using a computer-based monitor. Pharmacoepidemiol Drug Saf 2001; 10: 113-119
77. Peyriere H, Cassan S, Floutard E, et al. Adverse drug events associated with hospital admission. Ann Phar-macother 2003; 37: 5-11
78. Dormann H, Criege-Rieck M, Neubert A, et al. Lack of awareness of community-acquired adverse drug reactions upon hospital admission: dimensions and consequences of a dilemma. Drug Saf 2003; 26: 353-362
79. Hardmeier B, Braunschweig S, Cavallaro M, et al. Adverse drug events caused by medication errors in medical in-patients. Swiss Med Wkly 2004; 134: 664-670
80. Hallas J, Jensen KB, Grodum E, et al. Drug related ad-missions to a department of medical gastroenterology: the role of self-medicated and prescribed drugs. Scand J Gastroenterol 1991; 26: 174-180
81. Hallas J, Davidsen O, Grodum E, et al. Drug related illness as a cause of admission to a department of respiratory medicine. Respiration 1992; 59: 30-34
82. Hallas J, Gram LE, Grodum E, et al. Drug related admis-sions to medical wards: a population based survey. Br J Clin Pharmacol 1992; 33: 61-68
83. Easton KL, Parsons BJ, Starr M, et al. The incidence of drug-related problems as a cause of hospital admissions in children. Med J Aust 1998; 169: 356-359
84. Easton KL, Chapman CB, Brien J. Frequency and char-acteristics of hospital admissions associated with drug-related problems in paediatrics. Br J Clin Pharmacol 2004; 57: 611-615
85. Stewart RB, Sprinker PK, Adams JE. Drug-related ad-missions to an inpatient psychiatric unit. Am J Psychiatry 1980; 137: 1093-1095
86. Salem RB, Keane TM, Williams JG. Drug-related admis-sions to a Veterans' Administration psychiatric unit. Drug Intell Clin Pharm 1984; 18: 74-76
87. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitali-sations of the elderly. Arch Intern Med 1990; 150: 841-845
88. Wong ME, Ioannides-Demos LL, Li SC, et al. Drug-related hospital admissions of geriatric patients [abstract]. Aust J Hosp Pharm 1993; 23: 75
89. Courtman BJ, Stallings SB. Characterization of drug-related problems in elderly patients on admission to a medical ward. Can J Hosp Pharm 1995; 48: 161-166
90. Cunningham G, Dodd TR, Grant DJ, et al. Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. Age Ageing 1997; 26: 375-382
91. Malhotra S, Karan RS, Pandhi P, et al. Drug-related medical emergencies in the elderly: role of adverse drug reactions and non-compliance. Postgrad Med J 2001; 77: 703-707
92. Rivkin A. Admissions to a medical intensive care unit re-lated to adverse drug reactions. Am J Health Syst Pharm 2007; 64: 1840-1843
93. Frisk PA, Cooper JW, Campbell NA. Community-hospital pharmacist detection of drug-related problems upon patient admission to small hospitals. Am J Hosp Pharm 1977; 34: 738-742
94. Koh Y, Kutty FB, Li SC. Therapy related hospital admis-sion in patients on polypharmacy in Singapore: a pilot study. Pharm World Sci 2003; 25: 135-137
95. Kaufman DW, Kelly JP, Rosenberg L, et al. Recent pat-terns of medication use in the ambulatory adult population of the United States: the Slone Survey. JAMA 2002; 287: 337-344
96. Walker J, Wynne H. Review: the frequency and severity of adverse drug reactions in elderly people. Age Ageing 1994; 23: 255-259
97. Tranulis C, Skalli L, Lalonde P, et al. Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature. Drug Saf 2008; 31: 7-20
98. Rittmannsberger H, Meise U, Schauflinger K, et al. Poly-pharmacy in psychiatric treatment: patterns of psycho-tropic drug use in Austrian psychiatric clinics. Eur Psychiatry 1999; 14: 33-40
99. Bonati M. Epidemiological evaluation of drug use in chil-dren. J Clin Pharmacol 1994; 34: 300-305
100. Sturkenboom MC, Verhamme KM, Nicolosi A, et al. Drug use in children: cohort study in three European countries. BMJ 2008 Nov 24; 337: 1338-1341
101. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-1205
102. Wiffen P, Gill M, Edwards J, et al. Adverse drug reactions in hospital patients. Bandolier Extra 2002: 1-15 [online]. Available from URL: http://www.medicine.ox.ac.uk/bandolier/Extraforbando/ADRPM.pdf [Accessed 2009 May 7]
103. Kongkaew C, Noyce PR, Ashcroft DM. Hospital admis-sions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Phar-macother 2008; 42: 1017-1025